In conclusion, our study showed that in women under 30 years, cervical cancer screening model based on primary HPV testing with p16/Ki67 dual-staining triage of HPV-positive women can be an effective screening approach in detecting cervical precancers and provide superior diagnostic value when compared with primary cytology with reflex HPV or primary cytology alone models. This evidence concerns the gene MKI67 and cervical cancer.